www.ema.europa.eu PRAC recommends measures to minimise the risk of serious side effects with medicines containing pseudoephedrineEMA’s safety committee, PRAC, has recommended new measures for medicines containing pseudoephedrine to minimise the risks of posterior reversible encephalopathy...

www.ema.europa.eu European countries have substantially reduced sales of veterinary antibiotics, which translates into a lower risk of bacteria becoming resistant in people and animals. Overall sales of veterinary antibiotics decreased by 53% between 2011 and 2022, reaching the lowest level...

www.ema.europa.eu The Committee adopted by consensus positive opinions for variations requiring assessment concerning quality-related changes for:EquioxxOnsiorSimparica Trio, Felisecto Plus, MiPet Easecto, Simparica, Stronghold Plus (worksharing procedure) Vectormune ND, Newflend ND...

www.ema.europa.eu Eight new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended eight medicines for approval at its November 2023 meeting.The CHMP adopted a positive opinion for Omjjara* (momelotinib), for the treatment of myelofibrosis, a rare blood cancer...

www.ema.europa.eu The European Medicines Agency (EMA) is relaunching its corporate website on Tuesday 5 December.  From day one, EMA is giving its website a fresh look and feel. The website will also feature a new, simple medicines search, clearer navigation and a revamped What’s new...

www.ema.europa.eu This year marks the 10th anniversary of the International Coalition of Medicines Regulatory Authorities (ICMRA). ICMRA was established in December 2013 by eight regulators to address a need for a global governance mechanism and stronger cooperation. Today, ICMRA consists...